Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
He Wang(Nanjing Agricultural University), Yi Zhou(Guangzhou Medical University), Yugang Huang(State Key Laboratory of Respiratory Disease), Fangke Zhang(Guangzhou Medical University), LI Pei-yin(Guangzhou Medical University), Huaying Wen(Guangzhou Medical University), Wenwen Shi(State Key Laboratory of Respiratory Disease), Qiudi Huang(State Key Laboratory of Respiratory Disease), Jiacui Xie(Guangdong Pharmaceutical University), Jianhai Chen(Chicago Department of Public Health), Linghao Qin(Guangdong Pharmaceutical University)
Cited by 122
Related Papers
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
|Cancer Cell|2013|302
Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery
|Biomaterials|2011|183
Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells
|Journal of Nanobiotechnology|2017|105
Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis
|Proceedings of the National Academy of Sciences|2022|76
Assessment of Sleep in the National Social Life, Health, and Aging Project
|The Journals of Gerontology Series B|2014|63